Role of tumor microenvironment in cancer progression and therapeutic strategy
Q Wang, X Shao, Y Zhang, M Zhu, FXC Wang… - Cancer …, 2023 - Wiley Online Library
Cancer is now considered a tumor microenvironment (TME) disease, although it was
originally thought to be a cell and gene expression disorder. Over the past 20 years …
originally thought to be a cell and gene expression disorder. Over the past 20 years …
[HTML][HTML] Ferroptosis in life: To be or not to be
Ferroptosis is a novel type of programmed cell death, characterized by a dysregulated iron
metabolism and accumulation of lipid peroxides. It features the alteration of mitochondria …
metabolism and accumulation of lipid peroxides. It features the alteration of mitochondria …
Rescue of dendritic cells from glycolysis inhibition improves cancer immunotherapy in mice
Inhibition of glycolysis in immune cells and cancer cells diminishes their activity, and thus
combining immunotherapies with glycolytic inhibitors is challenging. Herein, a strategy is …
combining immunotherapies with glycolytic inhibitors is challenging. Herein, a strategy is …
Dietary glutamine supplementation suppresses epigenetically-activated oncogenic pathways to inhibit melanoma tumour growth
MB Ishak Gabra, Y Yang, H Li, P Senapati… - Nature …, 2020 - nature.com
Tumour cells adapt to nutrient deprivation in vivo, yet strategies targeting the nutrient poor
microenvironment remain unexplored. In melanoma, tumour cells often experience low …
microenvironment remain unexplored. In melanoma, tumour cells often experience low …
[HTML][HTML] A novel immune-related genes prognosis biomarker for melanoma: associated with tumor microenvironment
R Huang, M Mao, Y Lu, Q Yu, L Liao - Aging (Albany NY), 2020 - ncbi.nlm.nih.gov
Background: Melanoma is a cancer of the skin with potential to spread to other organs and is
responsible for most deaths due to skin cancer. It is imperative to identify immune …
responsible for most deaths due to skin cancer. It is imperative to identify immune …
Metabolic plasticity of melanoma cells and their crosstalk with tumor microenvironment
A Avagliano, G Fiume, A Pelagalli, G Sanità… - Frontiers in …, 2020 - frontiersin.org
Cutaneous melanoma (CM) is a highly aggressive and drug resistant solid tumor, showing
an impressive metabolic plasticity modulated by oncogenic activation. In particular …
an impressive metabolic plasticity modulated by oncogenic activation. In particular …
Comprehensive analysis of prognostic immune‐related genes in the tumor microenvironment of cutaneous melanoma
S Yang, T Liu, H Nan, Y Wang, H Chen… - Journal of cellular …, 2020 - Wiley Online Library
Cutaneous malignant melanoma (hereafter called melanoma) is one of the most aggressive
cancers with increasing incidence and mortality rates worldwide. In this study, we performed …
cancers with increasing incidence and mortality rates worldwide. In this study, we performed …
Characterization of glycolysis-associated molecules in the tumor microenvironment revealed by pan-cancer tissues and lung cancer single cell data
J Wei, K Huang, Z Chen, M Hu, Y Bai, S Lin, H Du - Cancers, 2020 - mdpi.com
Altered metabolism is a hallmark of cancer and glycolysis is one of the important factors
promoting tumor development. There is however still a lack of molecular characterization …
promoting tumor development. There is however still a lack of molecular characterization …
Metabolic flexibility in melanoma: A potential therapeutic target
MR Ruocco, A Avagliano, G Granato, E Vigliar… - Seminars in Cancer …, 2019 - Elsevier
Cutaneous melanoma (CM) represents one of the most metastasizing and drug resistant
solid tumors. CM is characterized by a remarkable metabolic plasticity and an important …
solid tumors. CM is characterized by a remarkable metabolic plasticity and an important …
Rethinking the biology of metastatic melanoma: A holistic approach
HHLD Vandyck, LM Hillen, FM Bosisio… - Cancer and Metastasis …, 2021 - Springer
Over the past decades, melanoma-related mortality has remained nearly stable. The main
reason is treatment failure of metastatic disease and the inherently linked knowledge gap …
reason is treatment failure of metastatic disease and the inherently linked knowledge gap …